Augmented Reality and Virtual Reality Medical Devices

The FDA's CDRH Patient Engagement Advisory Committee recently met to discuss and make recommendations on factors to consider when evaluating the benefits, risks, and uncertainty of AR/VR and its use as medical devices.

It's the first and only advisory committee whose members are all patients, caregivers, and representatives of patient organizations.

PEAC-July12-13-2022-Executive-Summary (fda.gov)